Evidence map›Paper›PMID 29568811›Full record

ArticleCurrent opinion in toxicology2018

Oxidative Stress and Metabolic Reprogramming in Cr(VI) Carcinogenesis.

Marco Clementino, Xianglin Shi, Zhuo Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Current opinion in toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Hexavalent chromium exposure impacts the metabolome of human lung fibroblast cells.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. [A Review of the Redox Regulation of Tumor Metabolism].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. The Metallome of Lung Cancer and its Potential Use as Biomarker.International journal of molecular sciences · 2019
    Review
  16. Article
  17. Investigating the Role of Mitochondrial Respiratory Dysfunction during Hexavalent Chromium-Induced Lung Carcinogenesis.Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marco ClementinoDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536.
Xianglin ShiCenter for Research on Environmental Diseases, University of Kentucky, Lexington, KY 40536.
Zhuo ZhangDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536.
University of Kentucky · US

Funding

Pilot Project ProgramP30ES026529 · NIEHS · UNIVERSITY OF KENTUCKY · PI John Anthony Bauer · 2017 to 2026
$15.4M
Oxidative stress, Cr(VI) carcinogenesis, and preventionR01ES025515 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN, ZHANG, ZHUO · 2015 to 2019
$2.9M
Apoptosis resistance and Cr(VI) carcinogenesisR01ES021771 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN, ZHANG, ZHUO · 2014 to 2018
$1.7M
NIEHS NIH HHS P30 ES026529NIEHS NIH HHS R01 ES021771NIEHS NIH HHS R01 ES025515
6 · The paper itself

Abstract

Cr(VI)-containing compounds are well-established lung carcinogens. Chronic exposure of the normal human epithelial cells is able to induce malignant cell transformation, the first stage of metal carcinogenesis. These Cr(VI)-transformed cells exhibit increased level of antioxidants, reduced capacity of generating reactive oxygen species (ROS), and development of apoptosis resistance, promoting tumorigenesis of Cr(VI)-transformed cells, the second stage of metal carcinogenesis. The mechanism of Cr(VI) induced carcinogenesis is still under investigation. Recent studies indicate that ROS play a positive role in the first stage while a negative role in the second stage. Transformed cells adapt metabolism to support tumor initiation and progression. Altered metabolic activities directly participate in the process of cell transformation or support a large requirement for nucleotides, amino acids, and lipids for tumor growth. In malignantly Cr(VI)-transformed cells, mitochondrial oxidative phosphorylation is defective, and pentose phosphate pathway, glycolysis, and glutaminolysis are upregulated. These metabolic reprogramming supports rapid cell proliferation and contributes to tumorigenesis of Cr(VI)-transformed cells. This article summarizes the current progress in the studies of metabolic reprogramming and Cr(VI) carcinogenesis with emphasis on the metabolic enzymes and oxidative stress related major oncogenic pathways.

Indexed as

CarcinogenesisChromium (VI)metabolic reprogrammingOxidative stress

Identifiers

PMID29568811
PMCPMC5858573
OpenAlexW2772035849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.